These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22781221)

  • 1. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.
    Li J; Gilmour S; Zhang H; Koyanagi A; Shibuya K
    AIDS; 2012 Oct; 26(16):2069-78. PubMed ID: 22781221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    Alistar SS; Owens DK; Brandeau ML
    PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
    Long EF; Brandeau ML; Galvin CM; Vinichenko T; Tole SP; Schwartz A; Sanders GD; Owens DK
    AIDS; 2006 Nov; 20(17):2207-15. PubMed ID: 17086061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors.
    Perngmark P; Vanichseni S; Celentano DD
    Drug Alcohol Depend; 2008 Jan; 92(1-3):183-90. PubMed ID: 17870252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
    Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
    Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
    Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
    Long EF; Brandeau ML; Owens DK
    Ann Intern Med; 2010 Dec; 153(12):778-89. PubMed ID: 21173412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A social cost-benefit criterion for evaluating Voluntary Counseling and Testing with an application to Tanzania.
    Brent RJ
    Health Econ; 2010 Feb; 19(2):154-72. PubMed ID: 19266590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and injecting drug use in Indonesia: epidemiology and national response.
    Afriandi I; Aditama TY; Mustikawati D; Oktavia M; Alisjahbana B; Riono P
    Acta Med Indones; 2009 Jul; 41 Suppl 1():75-8. PubMed ID: 19920303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.